Bank of Montreal
APLT

Bank of Montreal’s Applied Therapeutics APLT Stock Holding History

Bank of Montreal’s Portfolio APLT Stock Details APLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-12,200
Closed -$57.2K – 3846
2024
Q2 		$57.2K Buy
+12,200
New +$57.7K ﹤0.01% 3401
2023
Q1 		– Sell
-323,100
Closed -$355K – 3775
2022
Q4 		$355K Buy
+323,100
New +$256K ﹤0.01% 2812
2021
Q2 		– Sell
-510
Closed -$9K – 3698
2021
Q1 		$9K Sell
510
-1,605
-76% -$34.6K ﹤0.01% 4400
2020
Q4 		$49K Buy
2,115
+1,484
+235% +$30.9K ﹤0.01% 3947
2020
Q3 		$14K Sell
631
-440
-41% -$11.4K ﹤0.01% 3968
2020
Q2 		$33K Buy
+1,071
New +$44.8K ﹤0.01% 3617
2020
Q1 		– Sell
-807
Closed -$22K – 4079
2019
Q4 		$22K Buy
807
+630
+356% +$10.8K ﹤0.01% 4259
2019
Q3 		$2K Buy
+177
New +$1.67K ﹤0.01% 4633

Other funds holding APLT

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Bank of Montreal's APLT Position: Q3 2024 in Review

Bank of Montreal sold out of Applied Therapeutics (APLT) in Q3 2024, closing a stake of 12,200 shares — an estimated $57.2K sold.

Bank of Montreal first reported a position in APLT in Q3 2019 and held it in 8 quarters. The position peaked at $355K in Q4 2022. 126 funds tracked by Wall St. Rank hold APLT as of Q3 2024.

  • Bank of Montreal reported no remaining Applied Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Bank of Montreal sold 12,200 Applied Therapeutics shares in Q3 2024, an estimated $57.2K.
  • Bank of Montreal first reported a position in Applied Therapeutics in Q3 2019 and held it in 8 quarters.
  • Bank of Montreal's Applied Therapeutics position peaked at $355K in Q4 2022.
  • 126 funds tracked by Wall St. Rank held Applied Therapeutics as of Q3 2024.

Based on Bank of Montreal's 13F filing for Q3 2024, filed 13 Nov 2024.